Lakeland Regional Medical Center

(863) 687-1100

Lakeland Regional Cancer Center
Lakeland Regional Cancer Center
Lakeland Regional Cancer Center

Print Page

Follicular Lymphoma

Clinical Trial # GSK OMB 113676:

  • Ofatumumab versus single agent Rituxan for patients who have relapsed after having treatment containing Rituxan.
  • Patients must have a WHO grade of 1,2,3 A and have had a partial response or complete response that lasted at least 6 months.  Patients must have two lesions greater than 1.5 cm or one lesion greater than 2 cm.  Patients must have massive or progressive organomegaly OR cytopenia OR lymphoma related symptoms OR progressive or massive lymphadenopathy.
  • Exclusions include, but are not limited to, Positive Hepatitis B, active liver or biliary disease, chronic or current infection, stem cell transplant or radioimmunotherapy within the last six months.

© 2015 Lakeland Regional Medical Center